Dean L. Schorno, EVP & Chief Financial Officer at RIGEL PHARMACEUTICALS INC (RIGL), sold 12,628 shares at $1.14 ($14K) on 2024-02-05, disclosed to the SEC on 2024-02-06.
Open-market sale of $14k RIGL by EVP & Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.13 | 5,601 | $6K | 44.1% |
| 2 | $1.14 | 7,027 | $8K | 55.9% |
| Total | $1.14 avg | 12,628 | $14K | 100% |
| Filing → |
| RIGL | BUY | 2019-05-23 | $206K | — | Filing → |
| GHDX | SELL | 2014-06-13 | $110K | — | Filing → |
| GHDX | SELL | 2014-05-13 | $100K | — | Filing → |